Saruplase

Drug Profile

Saruplase

Alternative Names: CG 4509; Rescupase; scu-PA

Latest Information Update: 26 Nov 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Genentech; Grunenthal
  • Class Plasminogen activator enzymes; Thrombolytics
  • Mechanism of Action Plasminogen activator stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Myocardial infarction

Most Recent Events

  • 26 Nov 1999 Further data from the PRIMI study have been added to the Ischaemic Heart Disease and Thrombosis therapeutic trials sections
  • 08 Jun 1999 Five year data from the PRIMI study have been added to the Ischaemic Heart Disease and Thromboses therapeutic trials sections
  • 19 May 1999 Discontinued-preregistration for Myocardial infarction in European Union (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top